BRIEF published on 05/15/2025 at 07:12, 1 year 3 months ago Cantourage établit un nouveau record de revenus en avril 2025 Marché Européen Revenus Records Cannabis Médical Demande De Produits Trajectoire De Croissance
BRIEF published on 05/15/2025 at 07:09, 1 year 3 months ago AT&S Records Revenue Growth Amid Market Challenges Market Environment Cost Optimization Financial Forecast EBITDA Growth AT&S Revenue
BRIEF published on 05/15/2025 at 07:09, 1 year 3 months ago AT&S enregistre une croissance de son chiffre d'affaires malgré les défis du marché Prévisions Financières Optimisation Des Coûts Croissance De L'EBITDA Environnement Du Marché Chiffre D'affaires D'AT&S
BRIEF published on 05/15/2025 at 07:07, 1 year 3 months ago Thyssenkrupp Nucera Sees Growth in Sales and Earnings in Q2 Green Hydrogen Thyssenkrupp Nucera Electrolysis Technologies Chlor-alkali Q2 Sales Growth
BRIEF published on 05/15/2025 at 07:07, 1 year 3 months ago Thyssenkrupp Nucera enregistre une croissance de ses ventes et de ses bénéfices au deuxième trimestre Thyssenkrupp Nucera Hydrogène Vert Technologies D'électrolyse Croissance Des Ventes Au Deuxième Trimestre Chlore-alcali
BRIEF published on 05/15/2025 at 07:06, 1 year 3 months ago Strong Financial Year for Züblin Immobilien Holding AG Dividend Policy Market Outlook Vacancy Rate Net Rental Income Property Revaluation
BRIEF published on 05/15/2025 at 07:06, 1 year 3 months ago Exercice solide pour Züblin Immobilien Holding AG Politique De Dividendes Perspectives Du Marché Taux De Vacance Revenu Locatif Net Réévaluation De La Propriété
BRIEF published on 05/15/2025 at 07:05, 1 year 3 months ago SCHOTT Pharma Reports Strong Q2 2025 Performance Revenue Growth SCHOTT Pharma High-value Solutions Pharmaceutical Innovations Q2 2025 Results
BRIEF published on 05/15/2025 at 07:05, 1 year 3 months ago SCHOTT Pharma annonce de solides performances au deuxième trimestre 2025 SCHOTT Pharma Croissance Des Revenus Des Solutions À Forte Valeur Ajoutée Résultats Du Deuxième Trimestre 2025 Innovations Pharmaceutiques
BRIEF published on 05/15/2025 at 07:05, 1 year 3 months ago Relief Therapeutics Announces 2025 AGM Agenda Annual General Meeting Financial Statements Shareholder Voting Board Re-election Compensation Approval
Published on 08/19/2026 at 18:50, 1 hour 11 minutes ago AmeriTrust Auto Advances End-to-End Lease Remarketing Strategy
Published on 08/19/2026 at 16:00, 4 hours 1 minute ago Telefónica Chile and Amdocs Establish Strategic Multi-Year Agreement to Accelerate Modernization and Business Agility in Chile
Published on 08/19/2026 at 15:55, 4 hours 6 minutes ago Drill Permit Received for Storm Exploration's Gold Standard Project
Published on 08/19/2026 at 14:40, 5 hours 21 minutes ago Revive Therapeutics Outlines Strategy to Build a Biodefence and Pandemic Preparedness Therapeutics Portfolio
Published on 08/19/2026 at 13:00, 7 hours 1 minute ago UraniumX Discovery Corp. Provides Update On Transaction With Pond Technologies Holdings INC.
Published on 08/19/2026 at 16:51, 3 hours 10 minutes ago AUTODOC and Apollo Funds successfully conclude transformative partnership
Published on 08/19/2026 at 16:15, 3 hours 46 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 08/18/2026 at 18:00, 1 day 2 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 1 day 2 hours ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day 8 hours ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day 8 hours ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
